Novartis Beats Subpoenas In Jaw-Injuries Drug Suit

Law360, New York (September 17, 2013, 2:37 PM ET) -- A Florida federal judge last week refused to permit the subpoena of two Novartis Pharmaceuticals Corp. employees, in a lawsuit concerning jaw injuries allegedly caused by the bone drugs Aredia and Zometa, saying the employees are too far from the trial location.

Plaintiff Ruth Dopson-Troutt was diagnosed with breast cancer, which later metastasized to her hip and pelvic bones, and her oncologist prescribed Aredia and Zometa from 1999 to 2005. But after Dopson-Troutt had a tooth extracted, she began experiencing jaw pain caused by osteonecrosis of...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required